Your shopping cart is empty.
EP2785717 - Bibliographic data
Last update | 04/05/2022 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73)Owner |
Société NOVARTIS AG Lichtstrasse 35 4056 Basel Suisse |
(72)Inventors |
Pascal FURET CH-4002 Basel Suisse |
Vito GUAGNANO CH-4002 Basel Suisse |
|
Philipp HOLZER CH-4002 Basel Suisse |
|
Robert MAH CH-4002 Basel Suisse |
|
Keiichi MASUYA CH-4002 Basel Suisse |
|
Achim SCHLAPBACH CH-4002 Basel Suisse |
|
Stefan STUTZ CH-4002 Basel Suisse |
|
Andrea VAUPEL CH-4002 Basel Suisse |
|
(74)Agent |
Mail recipient STRANG, ANDREA JOSEPHINE ET AL Novartis Pharma AG Lichtstrasse 35 4056 Basel Suisse |
(21)Application number | EP12805775.9 |
(22)Application date | 11/28/2012 |
(11)Publication number | EP2785717 |
Grant date | 01/13/2016 |
(54)Invention title | COMPOSÉS PYRAZOLOPYRROLIDINE |
(51)International classification | C07D 487/04, A61K 31/4162, A61K 31/513, A61K 31/506, A61K 31/4439, A61P 35/00, A61K 31/4162, A61K 31/513, A61K 31/506, A61K 31/4439, A61P 35/00 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 201161564591 P (32) Date: 11/29/2011 (33) Country: US |
Initial application | None |
Divisional applications | None |
Expected annuity |
Annuity: 5 - Amount: 55€ - Due date 11/30/2016 Surtax: 5 - Amount: 11€ - Due date 06/01/2017 |
Last annuity | None |
Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2016/6, of 02/12/2016 |
History | Publication de la délivrance du brevet européen - Legal date 01/13/2016 |
Entrée en période de grâce du brevet d'invention - Legal date 12/01/2016 | |
Déchéance du brevet d'invention après période de grâce - Legal date 11/30/2016 |